Copyright Reports & Markets. All rights reserved.

Global Lung Cancer Diagnostic Tests Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Immunoassays
        • 1.2.1.2 Flow Cytometry
        • 1.2.1.3 Rapid Tests
        • 1.2.1.4 Molecular Assays
        • 1.2.1.5 Tissue Arrays
        • 1.2.1.6 Circulating Tumor Cells
        • 1.2.1.7 Pharmacodiagnostics
        • 1.2.1.8 Biomarkers
        • 1.2.1.9 Other Diagnostics Methods
      • 1.2.2 by Application
        • 1.2.2.1 Precision Medicine
        • 1.2.2.2 Personalized Medicine
        • 1.2.2.3 Cancer Monitoring
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Immunoassays Market, 2013-2018
      • 4.1.2 Flow Cytometry Market, 2013-2018
      • 4.1.3 Rapid Tests Market, 2013-2018
      • 4.1.4 Molecular Assays Market, 2013-2018
      • 4.1.5 Tissue Arrays Market, 2013-2018
      • 4.1.6 Circulating Tumor Cells Market, 2013-2018
      • 4.1.7 Pharmacodiagnostics Market, 2013-2018
      • 4.1.8 Biomarkers Market, 2013-2018
      • 4.1.9 Other Diagnostics Methods Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Immunoassays Market Forecast, 2019-2024
      • 4.2.2 Flow Cytometry Market Forecast, 2019-2024
      • 4.2.3 Rapid Tests Market Forecast, 2019-2024
      • 4.2.4 Molecular Assays Market Forecast, 2019-2024
      • 4.2.5 Tissue Arrays Market Forecast, 2019-2024
      • 4.2.6 Circulating Tumor Cells Market Forecast, 2019-2024
      • 4.2.7 Pharmacodiagnostics Market Forecast, 2019-2024
      • 4.2.8 Biomarkers Market Forecast, 2019-2024
      • 4.2.9 Other Diagnostics Methods Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Precision Medicine Market, 2013-2018
      • 5.1.2 Personalized Medicine Market, 2013-2018
      • 5.1.3 Cancer Monitoring Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Precision Medicine Market Forecast, 2019-2024
      • 5.2.2 Personalized Medicine Market Forecast, 2019-2024
      • 5.2.3 Cancer Monitoring Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Advpharma Inc
    • 8.2 AIT Austrian Institute of Technology GmbH
    • 8.3 Courtagen Life Sciences Inc
    • 8.4 DiagnoCure Inc. (Inactive)
    • 8.5 BioMark Diagnostics Inc.
    • 8.6 BioMarker Strategies LLC
    • 8.7 Emory University
    • 8.8 Epigenomics AG
    • 8.9 GlycoZym
    • 8.10 HalioDx SAS
    • 8.11 Louisville Bioscience, Inc.
    • 8.12 Mayo Clinic US

    9 Conclusion

    Summary
    The global Lung Cancer Diagnostic Tests market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Immunoassays
    Flow Cytometry
    Rapid Tests
    Molecular Assays
    Tissue Arrays
    Circulating Tumor Cells
    Pharmacodiagnostics
    Biomarkers
    Other Diagnostics Methods
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Advpharma Inc
    AIT Austrian Institute of Technology GmbH
    Courtagen Life Sciences Inc
    DiagnoCure Inc. (Inactive)
    BioMark Diagnostics Inc.
    BioMarker Strategies LLC
    Emory University
    Epigenomics AG
    GlycoZym
    HalioDx SAS
    Louisville Bioscience, Inc.
    Mayo Clinic US
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Precision Medicine
    Personalized Medicine
    Cancer Monitoring
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now